Psychosocial Risk Factors in Patients With Most Common Cardiovascular Diseases Such as Hypertension and Coronary Artery Disease (Based on Results From the Russian Multicenter COMET Study)

Background: Psychosocial risk factors (RFs) play a major role in the development and progression of cardiovascular diseases (CVDs).

Aim. The COMET study aimed to obtain current data on psychosocial RFs in outpatients with arterial hypertension (AH) and/or coronary heart disease (CHD) seen in primary care facilities in 30 cities of Russia.

Methods. In 2016-2017, a multicenter cross-sectional study was carried out involving 325 physicians from community primary care facilities who enrolled 2,775 patients with AH and/or CHD ≥ 55 years of age. However, only 73 CHD patients (2.6%) were not hypertensive, therefore, these patients were excluded from the analyses. As a result, current paper is based on the comparison of AH patients (n=1687) vs. participants with both CHD and AH (AH+CHD; n=1015). We collected patients’ socio-demographic data, clinical features, traditional and psychosocial RFs, such as anxiety and depression, stress level, type D personality, and treatment adherence.

Results. The study population (women, 72%; mean age ± SD, 66.7 ± 7.9 years) had a significant prevalence of psychosocial RF. 43.8% of AH patients and 45.5 % of participants with AH+CHD rated their income as low or very low, a low educational level was reported in 21.6% and 26.0%, respectively (both p=n/s). Social isolation was uncommon, but it occurred more frequently in AH+CHD patients (8.3% vs. 5.2%, p<0.01). Nevertheless, 40.2% of AH patients and 39.4% of AH+CHD were not married, and 26.0% and 24.6% were living alone, respectively. Elevated stress level was prevalent in more than 60% of patients (67.9% in AH patients vs. 67.7% in AH+CHD patents, p=n/s), and 63.3% and 64.8% of patients, respectively, reported stressful life events in the preceding year (p=n/s). Type D personality was more common in AH+CHD patients (41.2% vs. 35.8%; p<0.01). Clinically significant anxiety symptoms were prevalent in 24.7% ofAH patients and in 27.4% ofAH+CHD patients (p=n/s), and clinically significant depressive symptoms were identified in 13.9% and 20.9%, respectively (p<0.001).

Conclusion. We obtained current data on psychosocial RFs prevalence in outpatients with the most common CVDs in primary care setting. At the moment, their prevalence remains significant.

1. Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). European Heart Journal. 2016;37(29):2315-81. DOI: 10.1093/eurheartj/ehw106

2. Boytsov S.A., Pogosova N.V., Bubnova M.G., Drapkina O.M., Gavrilova N.E., Yeganyan R.A. et al. Cardiovascular prevention 2017. National guidelines. Russian Journal of Cardiology. 2018;23(6):7-122. DOI: 10.15829/1560-4071-2018-6-7-122

3. Pogosova N, Saner H, Pedersen SS, Cupples ME, McGee H, Hofer S et al. Psychosocial aspects in cardiac rehabilitation: From theory to practice. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation of the European Society of Cardiology. European Journal of Preventive Cardiology. 2015;22(10):1290-306. DOI: 10.1177/2047487314543075

4. Chida Y, Steptoe A. Positive Psychological Well-Being and Mortality: A Quantitative Review of Prospective Observational Studies: Psychosomatic Medicine. 2008;70(7):741-56. DOI: 10.1097/PSY.0b013e31818105ba

5. Cohen R, Bavishi C, Rozanski A. Purpose in Life and Its Relationship to All-Cause Mortality and Cardiovascular Events: A Meta-Analysis. Psychosomatic Medicine. 2016;78(2):122-33. DOI: 10.1097/PSY.0000000000000274

6. Silverman AL, Herzog AA, Silverman DI. Hearts and Minds: Stress, Anxiety, and Depression. Unsung Risk Factors for Cardiovascular Disease. Cardiology in Review. 2018;1. [Epub ahead of print]. DOI: 10.1097/CRD.0000000000000228

7. Gan Y, Gong Y, Tong X, Sun H, Cong Y, Dong X et al. Depression and the risk of coronary heart disease: a meta-analysis of prospective cohort studies. BMC Psychiatry. 2014;14(1):371. DOI: 10.1186/s12888-014-0371-z

8. Tully PJ, Cosh SM, Baumeister H. The anxious heart in whose mind? A systematic review and meta-regression of factors associated with anxiety disorder diagnosis, treatment and morbidity risk in coronary heart disease. Journal of Psychosomatic Research. 2014;77(6):439-48. DOI: 10.1016/j.jpsychores.2014.10.001

9. Angermann CE, Gelbrich G, Stork S, Gunold H, Edelmann F, Wachter R et al. Effect of Escitalopram on All-Cause Mortality and Hospitalization in Patients With Heart Failure and Depression: The MOOD-HF Randomized Clinical Trial. JAMA. 2016;315(24):2683-93. DOI: 10.1001/jama.2016.7635

10. Pogosova N, Kotseva K, De Bacquer D, von Kanel R, De Smedt D, Bruthans J et al. Psychosocial risk factors in relation to other cardiovascular risk factors in coronary heart disease: Results from the EUROASPIRE IV survey. A registry from the European Society of Cardiology. European Journal of Preventive Cardiology. 2017;24(13):1371-80. DOI: 10.1177/2047487317711334

11. Dennison ^A, Feldman AL, Usher-Smith JA, Griffin SJ. The association between psychosocial factors and change in lifestyle behaviour following lifestyle advice and information about cardiovascular disease risk. BMC Public Health. 2018;18(1):731. DOI: 10.1186/s12889-018-5655-7

12. Klainin-Yobas P, Ng SH, Stephen PDM, Lau Y. Efficacy of psychosocial interventions on psychological outcomes among people with cardiovascular diseases: a systematic review and meta-analysis. Patient Education and Counseling. 2016;99(4):512-21. DOI: 10.1016/j.pec.2015.10.020

13. Bangalore S, Shah R, Pappadopulos E, Deshpande CG, Shelbaya A, Prieto R et al. Cardiovascular hazards of insufficient treatment of depression among patients with known cardiovascular disease: a propensity score adjusted analysis. European Heart Journal -Quality of Care and Clinical Outcomes. 2018;4(4):258-66. DOI: 10.1093/ehjqcco/qcy023

14. Pogosova N.V., Boytsov S.A., Oganov R.G., Yufereva Yu.M., Kostyuk G.P., Kursakov A.A. et al. Clinical-Epidemiological Program of Studying Psychosocial Risk Factors in Cardiological Practice in Patients With Arterial Hypertension and Ischemic Heart Disease: First Results of a Multicenter Study in Russia. Kardiologiia. 2018;58(9):47-58. DOI: 10.18087/cardio.2018.9.10171

15. Pogosova N.V., Boytsov S.A., Oganov R.G., Kostyuk G.P., Sokolova O.Yu., Yufereva Yu.M. et al. Psychosocial Risk Factors in Ambulatory Patients With Arterial Hypertension and Ischemic Heart Disease of 30 Cities in Russia: Data from the КОМЕТА (Comet) Study. Kardiologiia. 2018;58(11):5-16. DOI: 10.18087/cardio.2018.11.10193

16. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica. 1983;67(6):361-70. PMID: 6880820

17. Denollet J. DS14: Standard Assessment of Negative Affectivity, Social Inhibition, and Type D Personality: Psychosomatic Medicine. 2005;67(1):89-97. DOI: 10.1097/01.psy.0000149256.81953.49

18. Shulman KI, Pushkar Gold D, Cohen CA, Zucchero CA. Clockdrawing and dementia in the community: A longitudinal study. International Journal of Geriatric Psychiatry. 1993;8(6):487-96. DOI: 10.1002/gps.930080606

19. Sogaro E, Schinina F, Burgisser C, Orso F, Pallante R, Aloi T et al. Type D personality impairs Quality of Life, coping and short-term psychological outcome in patients attending an outpatient intensive program of cardiac rehabilitation. Monaldi Archives for Chest Disease. 2015;74(4):181-91. DOI: 10.4081/monaldi.2010.259

20. Oliva F, Versino E, Gammino L, Colombi N, Ostacoli L, Carletto S et al. Type D Personality and Essential Hypertension in Primary Care: A Cross-Sectional Observational Study Within a Cohort of Patients Visiting General Practitioners. The Journal of Nervous and Mental Disease. 2016;204(1):43-8. DOI: 10.1097/NMD.0000000000000421

21. Pogosova N.V., Koltunov I.E., Sokolova O.Yu. Secondary prevention of arterial hypertension and coronary heart disease in real clinical practice of the Russian Federation. -М.: Vikas-print; 2009. - 151p.

22. ChazovE.I., Oganov R.G., Pogosova N.V., Shal'nova S.A., Romasenko L.V., Deev A.D. Clinico-Epidemiological Program of the Study of Depression in Cardiological Practice in Patients With Arterial Hypertension and Ischemic Heart Disease (COORDINATA): results of multicenter prospective. Kardiologiia. 2007;47(3):28-37.

23. Celano CM, Millstein RA, Bedoya CA, Healy BC, Roest AM, Huffman JC. Association between anxiety and mortality in patients with coronary artery disease: A meta-analysis. American Heart Journal. 2015;170(6):1105-15. DOI: 10.1016/j.ahj.2015.09.013

24. Player MS, Peterson LE. Anxiety Disorders, Hypertension, and Cardiovascular Risk: A Review. The InternationalJournal of Psychiatry in Medicine. 2011;41(4):365-77. DOI: 10.2190/PM.41.4.f

25. Caldirola D, Schruers KR, Nardi AE, De Berardis D, Fornaro M, Perna G. Is there cardiac risk in panic disorder? An updated systematic review. Journal of Affective Disorders. 2016;194:38-49. DOI: 10.1016/j.jad.2016.01.003

26. Whooley MA, WongJM. Depression and Cardiovascular Disorders. Annual Review of Clinical Psychology. 2013;9(1):327-54. DOI: 10.1146/annurev-clinpsy-050212-185526

27. Seligman F, Nemeroff CB. The interface of depression and cardiovascular disease: therapeutic implications: Depression and cardiovascular disease. Annals of the New York Academy of Sciences. 2015;1345(1):25-35. DOI: 10.1111/nyas.12738

28. Cohen BE, Edmondson D, Kronish IM. State of the Art Review: Depression, Stress, Anxiety, and Cardiovascular Disease. American Journal of Hypertension. 2015;28(11):1295-302. DOI: 10.1093/ajh/hpv047

29. Doyle F, McGee H, Conroy R, Conradi HJ, Meijer A, Steeds R et al. Systematic Review and Individual Patient Data Meta-Analysis of Sex Differences in Depression and Prognosis in Persons With Myocardial Infarction: A MINDMAPS Study. Psychosomatic Medicine. 2015;77(4):419-28. DOI: 10.1097/PSY.0000000000000174

30. Nasilowska-Barud A, Zapolski T, Barud M, Wysokinski A. Overt and Covert Anxiety as a Toxic Factor in Ischemic Heart Disease in Women: The Link Between Psychological Factors and Heart Disease. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research. 2017;23:751-8. PMID: 28187122

31. Lichtman JH, Froelicher ES, Blumenthal JA, Carney RM, Doering LV, Frasure-Smith N et al. Depression as a Risk Factor for Poor Prognosis Among Patients With Acute Coronary Syndrome: Systematic Review and Recommendations: A Scientific Statement From the American Heart Association. Circulation. 2014;129(12):1350-69. DOI: 10.1161/CIR.0000000000000019